Having established that RANBP9 and GID8 are upregulated while RANBP10 is downregulated or expressed at low levels in NSCLC patients, we next proceeded to assess their correlations with the global proteome in the CPTAC LUAD and LUSQ datasets. Here, GID8 is linked to non-small cell lung carcinoma.